Liquidia posts Q4 net income $14.6M; YUTREPIA sales $90.1M in Q4, $148.3M FY2025

Liquidia Corp

Q4 net income $14.6M, positive non-GAAP adjusted EBITDA $27.3M; FY net loss $68.9M vs $128.3M in 2024.
YUTREPIA net product sales $148.3M in FY2025 ($90.1M Q4) since launch in June 2025; no product revenue in 2024.
Cash and equivalents $190.7M at Dec 31, 2025, up from $176.5M at Dec 31, 2024.
Over 3,600 prescriptions and 2,900 patients started since launch; prescribers ~860, 25% have referred 5+ patients.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Liquidia Corp reported the year ended December 31, 2025 results: revenue $148.3 million, net income net loss of $68.9 million, EPS $0.80 per basic and diluted share.

Period: the year ended December 31, 2025
Revenue: $148.3 million
Net income: net loss of $68.9 million
EPS: $0.80 per basic and diluted share
Result: reported results

Exact text from the filing

99.1 Exhibit 99.1 Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update · Achieved YUTREPIA® net product sales of $148.3 million for the full year 2025 with $90.1 million in the fourth quarter · More than 3,600 unique prescriptions received and 2,900 patients treated to date since launch in June 2025 ·

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Liquidia Corp reported fourth quarter of 2025 results: revenue $90.1 million, net income net income of $14.6 million.

Period: fourth quarter of 2025
Revenue: $90.1 million
Net income: net income of $14.6 million
Result: reported results

Exact text from the filing

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update · Achieved YUTREPIA® net product sales of $148.3 million for the full year 2025 with $90.1 million in the fourth quarter · More than 3,600 unique prescriptions received and 2,900 patients treated to date since launch in June 2025 · Ended 2025 with $190.7 million in cash and

View on SEC.gov

Browse all earnings releases →

Liquidia Corp filing history →

Source: SEC EDGAR

accession 0001104659-26-023794

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.